Article
Minimizing risks: the ethics of predictive diabetes mellitus screening research in newborns.
Archives of pediatrics & adolescent medicine - 1 Jan 2003
Ross Lainie Friedman
Abstract excerpt
Type 1 diabetes mellitus is the most common metabolic disease of childhood. Two states offer newborn screening to identify children with a genetic predisposition to it. It is a voluntary test offered in conjunction with the mandatory newborn metabolic screening. There are no preventive treatments, but children discovered to be at increased risk may participate in follow-up studies to determine whether and when...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
